Collegium Pharmaceutical (COLL) Cash from Operations (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Cash from Operations of 57113000.0 for Q1 2026, up 3.1% year-over-year from 55398000.0 in Q1 2025, and down 53.58% quarter-over-quarter from 123048000.0 in Q4 2025.
Collegium Pharmaceutical (COLL) Cash from Operations (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Cash from Operations history runs 13 years deep, the most recent figure standing at 57113000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 3.1% year-over-year to 57113000.0; the TTM figure through Mar 2026 stood at 331038000.0 (up 66.82% YoY), while the FY2025 annual figure was 329323000.0, up 60.66% from the prior year.
- Cash from Operations for Q1 2026 stood at 57113000.0, down from 123048000.0 in the prior quarter.
- The five-year high for Cash from Operations was 123048000.0 in Q4 2025, with the low at 25315000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 66325000.0 (2022), against an average of 58258529.41.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations sank 223.07% in 2022, then soared 971.63% in 2025.
- Collegium Pharmaceutical's Cash from Operations stood at 66325000.0 in 2022, then advanced by 10.57% to 73338000.0 in 2023, then rose by 15.42% to 84644000.0 in 2024, then soared by 45.37% to 123048000.0 in 2025, then tumbled by 53.58% to 57113000.0 in 2026.
- Business Quant data shows COLL's Cash from Operations at 57113000.0 in Q1 2026, 123048000.0 in Q4 2025, and 78438000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn | 71.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.32 Mn |
| Jun 30, 2026 | 71.32 Mn |
| Mar 31, 2026 | 57.11 Mn |
| Mar 31, 2026 | 57.11 Mn |
| Dec 31, 2025 | 123.05 Mn |
| Dec 31, 2025 | 123.05 Mn |
| Sep 30, 2025 | 78.44 Mn |
| Sep 30, 2025 | 78.44 Mn |
| Jun 30, 2025 | 72.44 Mn |
| Jun 30, 2025 | 72.44 Mn |
| Mar 31, 2025 | 55.40 Mn |
| Mar 31, 2025 | 55.40 Mn |
| Dec 31, 2024 | 84.64 Mn |
| Dec 31, 2024 | 84.64 Mn |
| Sep 30, 2024 | -9.00 Mn |
| Sep 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | 67.40 Mn |
| Jun 30, 2024 | 67.40 Mn |
| Mar 31, 2024 | 61.94 Mn |
| Mar 31, 2024 | 61.94 Mn |